A direct co-investment fund aimed at growth stage innovative, R&D-intensive UK companies seeking relatively large investments.
Fund Information
- Funding body:
- The British Business Bank
- Maximum value:
- Discretionary
- Application deadline:
- None specified
Background
The Future Fund: Breakthrough was announced at Budget 202. It is funded by HM Treasury and is delivered by the Government’s British Business Bank, via its subsidiary British Patient Capital.
Objectives of Fund
The Future Fund: Breakthrough scheme has been created to drive investment in high growth, innovative, and research and development (R&D) intensive UK firms bringing game-changing technologies to market. The aim is to create new jobs and boost the country’s post-pandemic economic recovery.
Through the programme, the Government will co-invest with private investors to help scale-up innovations across high-growth firms. It is estimated that 1% growth in these firms could grow the UK economy by £38 billion.
Due to high R&D costs, breakthrough technology companies typically require more capital than other technology companies to fuel the later stages of their growth. Through the commercialisation of R&D, these companies can accelerate the deployment of innovative technologies that can transform major industries, develop new medicines, and support the transition to a net zero economy.
Value Notes
Support is provided as an equity investment. Alongside private sector investors, the Government will commit £375 million of funding to fast-growing firms looking to raise at least £30 million of investment. Companies must have raised at least £5 million in previous funding rounds. The maximum Future Fund: Breakthrough share of an investment round is 30%.
Who Can Apply
The scheme is open to R&D intensive companies with well- established UK operations, including life sciences, quantum computing and clean technology. To be eligible, businesses must have commitments of 70% of an investment round from private investors with a track record of financing innovative companies - such as venture capitalists.
The application must be made by a lead investor.
Restrictions
The fund will not invest in companies looking to develop or employ products with a short time-to-market, recognising that a strong private sector market for investment in these sectors already exists.
Location
United Kingdom.
How To Apply
The scheme is open for applications on a rolling basis.
Applications are made online at the programme website.
More details can be accessed here
Useful documents & links
Scheme - Guidance Document
Useful Links
Addresses and contacts
For further information on how to obtain this grant locally, please contact the following:
- British Patient Capital (BPC) Limited